Last updated: May 29, 2026

Application No. 17/998,592

STABILIZED CORONAVIRUS SPIKE PROTEIN FUSION PROTEINS

Non-Final OA

Filed

Nov 11, 2022

Priority

May 11, 2020 — provisional 63/022,776 +2 more

Examiner

WANG, RUIXUE

Art Unit

1672

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Janssen Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +23.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 99 resolved cases, 2023–2026

Examiner Intelligence

WANG, RUIXUE View full profile →

Grants 58% of resolved cases

Career Allowance Rate

57 granted / 99 resolved

-2.4% vs TC avg

Strong +23% interview lift

Without

With

+23.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

45 currently pending

Career history

164

Total Applications

across all art units

Statute-Specific Performance

§101

1.9%

-38.1% vs TC avg

§103

76.7%

+36.7% vs TC avg

§102

5.4%

-34.6% vs TC avg

§112

12.3%

-27.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 99 resolved cases

Prosecution Timeline

Nov 11, 2022

Application Filed

Sep 09, 2025

Non-Final Rejection mailed

Apr 21, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/762,472

Patent 12637704

COMPOSITION AND METHOD FOR IMPROVING DETECTION OF BIOMOLECULES IN BIOFLUID SAMPLES

4y 2m to grant Granted May 26, 2026

17/888,131

Patent 12577589

VACCINES AND USES THEREOF TO INDUCE AN IMMUNE RESPONSE TO SARS-COV2

3y 7m to grant Granted Mar 17, 2026

19/178,522

Patent 12576119

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

11m to grant Granted Mar 17, 2026

18/298,529

Patent 12570963

GENE THERAPIES FOR LYSOSOMAL DISORDERS

2y 11m to grant Granted Mar 10, 2026

17/594,113

Patent 12553893

MULTIPLEX COMPETITION ASSAY FOR PROFILING BINDING EPITOPES OF AFFINITY AGENTS FOR CLINICAL DIAGNOSTICS USE

4y 4m to grant Granted Feb 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

81%

With Interview (+23.2%)

3y 3m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 99 resolved cases by this examiner. Grant probability derived from career allowance rate.